Home
Kjell-Morten Myhr's picture

Kjell-Morten Myhr

Head of Department
  • E-mailKjell-Morten.Myhr@uib.no
  • Phone+47 55 97 60 31+47 414 47 868
  • Visitor Address
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Bjørnevik, Kjetil Lauvland; Riise, Trond; Cortese, Marianna; Holmøy, Trygve; Kampman, Margitta Theodora; Magalhaes, Sandra; Myhr, Kjell-Morten; Wolfson, Christina; Pugliatti, Maura. 2016. Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study. Multiple Sclerosis. 104-111.
  • Røsjø, Egil Rørvik; Myhr, Kjell-Morten; Løken-Amsrud, Kristin Ingeleiv; Bakke, Søren Jacob; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Lilleås, Finn G.; Midgard, Rune; Pedersen, Tom; Saltyte Benth, Jurate; Torkildsen, Øivind; Wergeland, Stig; Michelsen, Annika; Aukrust, Pål; Ueland, Thor; Holmøy, Trygve. 2015. Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis. Journal of Neuroimmunology. 21-28.
  • Cortese, Marianna; Riise, Trond; Bjørnevik, Kjetil Lauvland; Holmøy, Trygve; Kampman, Margitta Theodora; Magalhaes, Sandra; Pugliatti, Maura; Wolfson, Christina; Myhr, Kjell-Morten. 2015. Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study. Multiple Sclerosis. 1856-1864.
  • Magalhaes, Sandra; Pugliatti, Maura; Casetta, Ilaria; Drulovic, Jelena; Granieri, Enrico; Holmøy, Trygve; Kampman, Margitta Theodora; Landtblom, Anne-Marie; Lauer, Klaus; Myhr, Kjell-Morten; Parpinel, Maria; Pekmezovic, Tatjana; Riise, Trond; Wolfson, David; Zhu, Bin; Wolfson, Christina. 2015. The EnvIMS study: Design and methodology of an international case-control study of environmental risk factors in multiple sclerosis. Neuroepidemiology. 173-181.
  • Ragnedda, Giammario; Leoni, Stefania; Parpinel, Maria; Casetta, Ilaria; Riise, Trond; Myhr, Kjell-Morten; Wolfson, Christina; Pugliatti, Maura. 2015. Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study. Journal of Neurology. 1271-1277.
  • Kroksveen, Ann Cathrine; Jaffe, Jacob D.; Aasebø, Elise; Barsnes, Harald; Bjørlykke, Yngvild; Franciotta, Diego; Keshishian, Hasmik; Myhr, Kjell-Morten; Opsahl, Jill Anette; van Pesch, Vincent; Teunissen, Charlotte E.; Torkildsen, Øivind; Ulvik, Rune Johan; Vethne, Heidrun; Carr, Steven A.; Berven, Frode. 2015. Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis. Proteomics. 3361-3369.
  • Fjær, Sveinung; Bø, Lars; Myhr, Kjell-Morten; Torkildsen, Øivind; Wergeland, Stig. 2015. Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model. Neurochemistry International. 28-40.
  • Westerlind, Helga; Imrell, Kerstin; Ramanujam, Ryan; Myhr, Kjell-Morten; Celius, Elisabeth Gulowsen; Harbo, Hanne Flinstad; Oturai, Annette Bang; Hamsten, Anders; Alfredsson, Lars; Olsson, Tomas; Kockum, Ingrid; Koski, Timo; Hillert, Jan. 2015. Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort. European Journal of Human Genetics. 688-692.
  • Sundal, Christina Heidemann; Baker, Matt C.; Karrenbauer, Virginija Danylaité; Gustavsen, Marte Wendel; Bedri, Sahl Khalid; Glaser, Anna; Myhr, Kjell-Morten; Haugarvoll, Kristoffer; Zetterberg, Henrik; Harbo, Hanne Flinstad; Kochum, Ingrid; Hillert, Jan; Wszolek, Zbigniew K.; Rademakers, Rosa; Andersen, Oluf. 2015. Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis. European Journal of Neurology. 328-333.
  • Goris, An; Pauwels, Ine; Gustavsen, Marte Wendel; Van Son, Brechtje; Hilven, Kelly; Bos, Steffan Daniel; Celius, Elisabeth Gulowsen; Berg-Hansen, Pål; Aarseth, Jan Harald; Myhr, Kjell-Morten; D'Alfonso, Sandra; Barizzone, Nadia; Leone, Maurizio A.; Boneschi, Filippo Martinelli; Sorosina, Melissa; Liberatore, Giuseppe; Kockum, Ingrid; Olsson, Tomas; Hillert, Jan; Alfredsson, Lars; Bedri, Sahl Khalid; Hemmer, Bernhard; Buck, Dorothea; Berthele, Achim; Knier, Benjamin; Biberacher, Viola; Van Pesch, Vincent; Sindi, Christian; Oturai, Annette Bang; Søndergaard, Helle Bach; Sellebjerg, Finn; Jensen, Poul Erik Hyldgaard; Comabella, Manuel; Montalban, Xavier; Pérez-Boza, Jennifer; Malhotra, Sunny; Lechner-Scott, Jeannette; Broadley, Simon; Slee, Mark; Taylor, Bruce; Kermode, Allan G.; Gourraud, Pierre-Antoine; Sawcer, Stephen; Kulle, Bettina; Dubois, Bénédicte; Harbo, Hanne Flinstad. 2015. Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. Brain. 632-643.
  • Alme, Maria Nordheim; Nystad, Agnes Elisabeth; Bø, Lars; Myhr, Kjell-Morten; Vedeler, Christian A.; Wergeland, Stig; Torkildsen, Øivind. 2015. Fingolimod does not enhance cerebellar remyelination in the cuprizone model. Journal of Neuroimmunology. 180-186.
  • Kroksveen, Ann Cathrine; Opsahl, Jill Anette; Guldbrandsen, Astrid; Myhr, Kjell-Morten; Oveland, Eystein; Torkildsen, Øivind; Berven, Frode. 2015. Cerebrospinal fluid proteomics in multiple sclerosis. Biochimica et Biophysica Acta - Proteins and Proteomics. 746-756.
  • Wesnes, Kristin; Riise, Trond; Casetta, Ilaria; Drulovic, Jelena; Granieri, Enrico; Holmøy, Trygve; Kampman, Margitta Theodora; Landtblom, Anne Marie; Lauer, Klaus; Lossius, Peter Andreas Vold; Magalhaes, Sandra; Pekmezovic, Tatjana; Bjørnevik, Kjetil Lauvland; Wolfson, Christina; Pugliatti, Maura; Myhr, Kjell-Morten. 2015. Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study. Multiple Sclerosis. 388-395.
  • Bjørnevik, Kjetil Lauvland; Riise, Trond; Casetta, Ilaria; Drulovic, Jelena; Granieri, Enrico; Holmøy, Trygve; Kampman, Margitta Theodora; Landtblom, Anne-Marie; Lauer, Klaus; Lossius, Peter Andreas Vold; Magalhaes, Sandra; Myhr, Kjell-Morten; Pekmezovic, Tatjana; Wesnes, Kristin; Wolfson, Christina; Pugliatti, Maura. 2014. Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study. Multiple Sclerosis. 1042-1049.
  • Gustavsen, Marte Wendel; Viken, Marte K; Celius, Elisabeth Gulowsen; Berge, Tone; Mero, Inger-Lise; Berg-Hansen, Pål; Aarseth, Jan Harald; Myhr, Kjell-Morten; Søndergaard, Helle Bach; Sellebjerg, Finn; Oturai, Annette Bang; Hillert, Jan; Alfredsson, Lars; Olsson, Tomas; Kockum, Ingrid; Lie, Benedicte Alexandra; Harbo, Hanne Flinstad. 2014. Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general. Journal of Neuroimmunology. 174-179.
  • Torkildsen, Øivind Fredvik; Aarseth, Jan Harald; Benjaminsen, Espen; Celius, Elisabeth Gulowsen; Holmøy, Trygve; Kampman, Margitta Theodora; Løken-Amsrud, Kristin Ingeleiv; Midgard, Rune; Myhr, Kjell-Morten; Riise, Trond; Grytten, Nina Agnethe. 2014. Month of birth and risk of multiple sclerosis: confounding and adjustments. Annals of clinical and translational neurology. 141-144.
  • Røsjø, Egil Rørvik; Myhr, Kjell-Morten; Løken-Amsrud, Kristin Ingeleiv; Bakke, Jacob; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Lilleås, Finn; Midgard, Rune; Pedersen, Tom; Saltyte Benth, Jurate; Torkildsen, Øivind; Wergeland, Stig; Michelsen, Annika ; Aukrust, Pål; Ueland, Thor; Holmøy, Trygve. 2014. Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis. Journal of Neuroimmunology. 60-65.
  • Guldbrandsen, Astrid; Vethne, Heidrun; Farag, Yehia Mohamed Mokhtar; Oveland, Eystein; Garberg, Hilde Kristin; Berle, Magnus Foldal; Myhr, Kjell-Morten; Opsahl, Jill Anette; Barsnes, Harald; Berven, Frode. 2014. In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR). Molecular & Cellular Proteomics. 3152-3163.
  • Olberg, Henning Kristian; Cox, Rebecca Jane; Nøstbakken, Jane Kristin; Aarseth, Jan Harald; Vedeler, Christian A.; Myhr, Kjell-Morten. 2014. Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: An explorative study. Multiple Sclerosis. 1074-1080.
  • Klevan, Gry; Jacobsen, Cecilie Osman; Aarseth, Jan Harald; Myhr, Kjell-Morten; Nyland, Harald Inge; Glad, Solveig B; Lode, Kirsten; Figved, Nanna; Larsen, Jan Petter; Farbu, Elisabeth. 2014. Health related quality of life in patients recently diagnosed with multiple sclerosis. Acta Neurologica Scandinavica. 21-26.
  • Aasebø, Elise; Opsahl, Jill Anette; Bjørlykke, Yngvild; Myhr, Kjell-Morten; Kroksveen, Ann Cathrine; Berven, Frode. 2014. Effects of blood contamination and the rostro-caudal gradient on the human cerebrospinal fluid proteome. PLOS ONE.
  • Nystad, Agnes Elisabeth; Wergeland, Stig; Aksnes, Lage; Myhr, Kjell-Morten; Bø, Lars; Torkildsen, Øivind. 2014. Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model. APMIS : Acta pathologica, microbiologica et immunologica Scandinavica. Supplementum. 1178-1186.
  • Gavasso, Sonia; Mosleth, Ellen Færgestad; Marøy, Tove Helene; Jørgensen, Katarina Mariann; Nakkestad, Hanne Linda; Gjertsen, Bjørn Tore; Myhr, Kjell-Morten; Vedeler, Christian A. 2014. Deficient phosphorylation of stat-1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-beta. PLOS ONE.
  • Jacobsen, Cecilie Osman; Hagemeier, Jesper; Myhr, Kjell-Morten; Nyland, Harald Inge; Lode, Kirsten; Bergsland, Niels; Ramasamy, Deepa Preeti; Dalaker, Turi Olene; Larsen, Jan Petter; Farbu, Elisabeth; Zivadinov, Robert. 2014. Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study. Journal of Neurology, Neurosurgery and Psychiatry. 1109-1115.
  • Stokke, Silje Agnethe; Myhr, Kjell-Morten; Holmøy, Trygve; Bakke, Søren Jacob; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Løken-Amsrud, Kristin Ingeleiv; Lilleås, Finn; Midgard, Rune; Njølstad, Gro; Pedersen, Tom; Saltyte Benth, Jurate; Wergeland, Stig; Torkildsen, Øivind Fredvik. 2014. Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis. Multiple Sclerosis. 1833-1840.
  • Kampman, Margitta Theodora; Aarseth, Jan Harald; Grytten, Nina Agnethe; Benjaminsen, Espen; Celius, Elisabeth Gulowsen; Dahl, Ole-Petter; Holmøy, Trygve; Løken-Amsrud, Kristin Ingeleiv; Midgard, Rune; Myhr, Kjell-Morten; Risberg, Geir; Vatne, Anita; Torkildsen, Øivind. 2013. Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway. Journal of Neurology. 1481-1488.
  • Løken, Kristin Ingeleiv; Myhr, Kjell-Morten; Bakke, Jacob; Beiske, Antonie Giæver; Bjerve, Kristian S; Bjørnarå, Bård T.; Hovdal, Harald Olav; Lilleås, Finn; Midgard, Rune; Pedersen, Tom; Saltyte Benth, Jurate; Torkildsen, Øivind; Wergeland, Stig; Holmøy, Trygve. 2013. Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis. Multiple Sclerosis. 451-457.
  • Mero, Inger-Lise; Gustavsen, Marte Wendel; Sæther, Hanne Skarpodde; Flåm, Siri Tennebø; Berg-Hansen, Pål; Søndergaard, Helle Bach; Jensen, Poul Erik Hyldgaard; Berge, Tone; Bjølgerud, Anja; Muggerud, Aslaug; Aarseth, Jan Harald; Myhr, Kjell-Morten; Celius, Elisabeth Gulowsen; Sellebjerg, Finn; Hillert, Jan; Alfredsson, Lars; Olsson, Tomas; Oturai, Annette Bang; Kockum, Ingrid; Lie, Benedicte Alexandra; Kulle, Bettina; Harbo, Hanne Flinstad. 2013. Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles. PLOS ONE. 9 pages.
  • Ban, Maria; Caillier, Stacy; Mero, Inger-Lise; Myhr, Kjell-Morten; Celius, Elisabeth Gulowsen; Aarseth, Jan Harald; Torkildsen, Øivind; Harbo, Hanne Flinstad; Oksenberg, Jorge; Hauser, Stephen L; Sawcer, Stephen; Compston, Alastair. 2013. No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis. Annals of Neurology. 430-432.
  • Baranzini, SE; Celius, E.G.; Elovaara, I; Harbo, HF; Hillert, J; Myhr, Kjell-Morten; Sørensen, PS; Spurkland, A; Sawcer, S; Hauser, SL; Oksenberg, JR; Khankhanian, Pouya; Patsopoulos, Nikolaos A.; Li, Michael; Stankovich, Jim; Cotsapas, Chris; Søndergaard, Helle Bach; Ban, Maria; Barizzone, Nadia; Bergamaschi, Laura; Booth, David; Buck, Dorothea; Cavalla, Paola; Celius, Elisabeth G.; Comabella, Manuel; Comi, Giancarlo; Compston, Alastair; Cournu-Rebeix, Isabelle; D’alfonso, Sandra; Damotte, Vincent; Din, Lennox; Dubois, Benedicte; Elovaara, Irina; Esposito, Federica; Fontaine, Bertrand; Franke, Andre; Goris, An; Gourraud, Pierre-Antoine; Graetz, Christiane; Guerini, Franca R.; Guillot-Noel, Lena; Hafler, David A; Hakonarson, Hakon; Hall, Per; Hamsten, Anders; Harbo, Hanne Flinstad; Bernhard, Hemmer; Hillert, Jan; Kemppinen, Anu; Ingrid, Kockum; Koivisto, Keijo; Larsson, Malin; Lathrop, Mark; Leone, Maurizio; Lill, Christina M.; Macciardi, Fabio; Martin, Roland; Martinelli, Vittorio; Martinelli-Boneschi, Filippo; McCauley, Jacob L.; Naldi, Paoloa; Olsson, Tomas; Oturai, Annette; Pericak-Vance, Margaret A.; Perla, Franco; Reunanen, Mauri; Saarela, Janna; Saker-Delye, Safa; Salvetti, Marco; Sellebjerg, Finn; Sørensen, Per Soelberg; Spurkland, Anne; Stewart, Graeme; Taylor, Bruce; Tienari, Pentti; Winkelmann, Juliane; Wellcome Trust Case Control, Consortium 2; Zipp, Frauke; Ivinson, Adrian J; Haines, Jonathan L.; Sawcer, Stephen; DeJager, Philip; Hauser, Stephen L; Oksenberg, Jorge R. 2013. Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls. American Journal of Human Genetics. 854-865.
  • Grytten, Nina Agnethe; Torkildsen, Øivind; Aarseth, Jan Harald; Benjaminsen, Espen; Celius, Elisabeth Gulowsen; Dahl, Ole-Petter; Holmøy, Trygve; Løken-Amsrud, Kristin Ingeleiv; Midgard, Rune; Myhr, Kjell-Morten; Risberg, Geir; Vatne, Anita; Kampman, Margitta Theodora. 2013. Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway. Multiple Sclerosis. 1028-1034.
  • Holmøy, Trygve; Løken-Amsrud, Kristin Ingeleiv; Bakke, Jacob; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Lilleås, Finn; Midgard, Rune; Pedersen, Tom; Saltyte Benth, Jurate; Torkildsen, Øivind; Wergeland, Stig; Myhr, Kjell-Morten; Michelsen, Annika ; Aukrust, Pål; Ueland, Thor. 2013. Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity. PLOS ONE. 9 pages.
  • Torkildsen, Øivind; Løken-Amsrud, Kristin Ingeleiv; Wergeland, Stig; Myhr, Kjell-Morten; Holmøy, Trygve. 2013. Fat-soluble vitamins as disease modulators in multiple sclerosis. Acta Neurologica Scandinavica. 16-23.
  • Salzer, Jonatan; Myhr, Kjell-Morten. 2013. Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: No. Multiple Sclerosis. 1692-1693.
  • Kroksveen, Ann Cathrine; Aasebø, Elise; Vethe, Heidrun; van Pesch, Vincent; Franciotta, Diego; Teunissen, Charlotte E.; Ulvik, Rune Johan; Vedeler, Christian A.; Myhr, Kjell-Morten; Barsnes, Harald; Berven, Frode. 2013. Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM. Journal of Proteomics. 312-325.
  • Olsson, Tomas; Achiron, Anat; Alfredsson, Lars; Berger, Thomas; Brassat, David; Chan, Andrew; Comi, Giancarlo; Eraksoy, Mefkure; Hegen, Harald; Hillert, Jan; Jensen, Poul Erik Hyldgaard; Moiola, Lucia; Myhr, Kjell-Morten; Oturai, Annette; Schippling, Sven; Siva, Aksel; Sørensen, Per Soelberg; Trampe, Anne-Kathrin; Weber, Thomas; Potts, James; Plavina, Tatiana; Paes, Dominic; Subramanyam, Meena; Wiendl, Heinz; Dib, Hussein; Üren, Deniz; Hemmer, Bernhard; Buck, Dorothea. 2013. Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort. Multiple Sclerosis. 1533-1538.
  • Løken-Amsrud, Kristin Ingeleiv; Myhr, Kjell-Morten; Bakke, Søren Jacob; Beiske, Antonie Giæver; Bjerve, Kristian S; Bjørnarå, Bård T.; Hovdal, Harald Olav; Lilleås, Finn; Midgard, Rune; Pedersen, Tom; Saltyte Benth, Jurate; Torkildsen, Øivind; Wergeland, Stig; Holmøy, Trygve. 2013. Alpha-tocopherol and MRI outcomes in multiple sclerosis - association and prediction. PLOS ONE. 5 pages.
  • Rosella, Mechelli; Renato, Umeton; Policano, Claudia; Annibali, Viviana; Giulia, Coarelli; Ricigliano, Vito A. G.; Vittori, Danila; Fornasiero, Arianna; Buscarinu, Maria Chiara; Sawcer, Stephen; Hellenthal, Garrett; Pirinen, Matti; Spencer, Chris C A; Patsopoulos, Nikolaos; Mousianas, Loukas; Dithey, Alexander; Su, Zhan; Freeman, Colin; Hunt, Sarah E; Edkins, Sarah; Gray, Emma; Booth, David R; Potter, Simon C; Goris, An; Band, Gavin; Oturai, Annette Bang; Strange, Amy; Saarela, Janna; Bellenguez, Celine; Fontaine, Bertrand; Gillman, Matthew; Hemmer, Bernhard; Gwilliam, Rhian; Zipp, Frauke; Jayakumar, Akagurevathi; Martin, Roland; Leslie, Stephen; Hawkins, Stanley; Giannolatou, Eleni; D`alfonso, Sandra; Blackburn, Hannah; Boneschi, Fillippo Martinelli; Liddle, Jennifer; Harbo, Hanne Flinstad; Perez, Marc L; Spurkland, Anne; Waller, Matthew J; Mycko, Marcin P; Ricketts, Michelle; Comabella, Manuel; Celius, Elisabeth Gulowsen; Lorentzen, Åslaug Rudjord; Mero, Inger-Lise; Myhr, Kjell-Morten; SMESTAD, CATHRINE. 2013. A ‘‘candidate-interactome’’ aggregate analysis of genome-wide association data in multiple sclerosis. PLOS ONE.
  • Torkildsen, Øivind; Wergeland, Stig; Bakke, Jacob; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Midgard, Rune; Lilleås, Finn; Pedersen, Tom; Bjørnarå, Bård T.; Dalene, Frøydis Christiane Moan; Kleveland, Grethe; Schepel, Jan; Olsen, Inge Christoffer; Myhr, Kjell-Morten. 2012. ω-3 fatty acid treatment in multiple sclerosis (OFAMS study): a randomised, double blind, placebo-controlled trial. Archives of Neurology. 1044-1051.
  • Holmøy, Trygve; Torkildsen, Øivind; Myhr, Kjell-Morten; Løken-Amsrud, Kristin Ingeleiv. 2012. Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore. Acta Neurologica Scandinavica. 63-69.
  • Løken-Amsrud, Kristin Ingeleiv; Holmøy, Trygve; Bakke, Søren J.; Beiske, Antonie Giæver; Bjerve, Kristian S; Bjørnarå, Bård T.; Hovdal, Harald Olav; Lilleås, Finn; Midgard, Rune; Pedersen, Tom; Saltyte Benth, Jurate; Sandvik, Leiv; Torkildsen, Øivind; Wergeland, Stig; Myhr, Kjell-Morten. 2012. Vitamin D and disease activity in multiple sclerosis before and during interferon beta treatment. Neurology. 267-273.
  • Wergeland, Stig; Torkildsen, Øivind; Myhr, Kjell-Morten; Mørk, Sverre; Bø, Lars. 2012. The cuprizone model: regional heterogeneity of pathology. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 648-657.
  • Svendsen, Bjørn; Myhr, Kjell-Morten; Nyland, Harald Inge; Aarseth, Jan Harald. 2012. The cost of multiple sclerosis in Norway. European Journal of Health Economics. 81-91.
  • Myhr, Kjell-Morten; Grytten, Nina Agnethe; Aarseth, Jan Harald. 2012. The Norwegian Multiple Sclerosis Registry and Biobank. Acta Neurologica Scandinavica. 20-23.
  • Lunde, Hanne Marie; Aae, Tommy Frøseth; Indrevåg, William; Aarseth, Jan Harald; Bjorvatn, Bjørn; Myhr, Kjell-Morten; Bø, Lars. 2012. Poor Sleep in Patients with Multiple Sclerosis. PLOS ONE. 5 pages.
  • Mero, Inger-Lise; SMESTAD, CATHRINE; Lie, Benedicte Alexandra; Lorentzen, Åslaug Rudjord; Sandvik, Leiv; Landrø, Nils Inge; Aarseth, Jan Harald; Myhr, Kjell-Morten; Celius, Elisabeth Gulowsen; Harbo, Hanne Flinstad. 2012. Polymorphisms of the BDNF gene show neither association with multiple sclerosis susceptibility nor clinical course. Journal of Neuroimmunology. 107-110.
  • Torkildsen, Øivind; Grytten, Nina Agnethe; Aarseth, Jan Harald; Myhr, Kjell-Morten; Kampman, Margitta Theodora. 2012. Month of birth as a risk factor for multiple sclerosis: an update. Acta Neurologica Scandinavica. 58-62.
  • Saltyte Benth, Jurate; Myhr, Kjell-Morten; Løken-Amsrud, Kristin Ingeleiv; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Midgard, Rune; Holmøy, Trygve. 2012. Modelling and Prediction of 25-Hydroxyvitamin D Levels in Norwegian Relapsing-Remitting Multiple Sclerosis Patients. Neuroepidemiology. 84-93.
  • Gavasso, Sonia; Gjertsen, Bjørn Tore; Anderssen, Endre; Myhr, Kjell-Morten; Vedeler, Christian A. 2012. Immunogenic effects of recombinant interferon-beta therapy disrupt the JAK/STAT pathway in primary immune cells from patients with multiple sclerosis. Multiple Sclerosis. 1116-1124.
  • Gavasso, Sonia; Torkildsen, Øivind; Marøy, Tove Helene; Ulvestad, Elling; Myhr, Kjell-Morten; Vedeler, Christian A. 2012. Fcγ receptors in Norwegian multiple sclerosis patients and healthy controls. Acta Neurologica Scandinavica, Supplementum. 84-89.
  • Kroksveen, Ann Cathrine; Guldbrandsen, Astrid; Vedeler, Christian A.; Myhr, Kjell-Morten; Opsahl, Jill Anette; Berven, Frode. 2012. Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls. Acta Neurologica Scandinavica. 90-96.
  • Pugliatti, M; Eskic, D.; Mikolcic, T; Pitschnau-Michel, D; Myhr, Kjell-Morten; Sastre-Garriga, J; Otero, Jaime; Wieczynska, L; Torje, C; Holloway, E; Rienhoff, O; Friede, T.; Buckow, K; Ellenberger, D.; Hillert, J; Glaser, A.; Flachenecker, P.; Fuge, J; Schyns-Liharska, T; Kasilingam, E; Morettei, A; Thalheim, C. 2012. Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS. Acta Neurologica Scandinavica. 24-30.
  • Pugliatti, Maura; Casetta, Ilaria; Drulovic, Jelena; Granieri, Enrico; Holmøy, Trygve; Kampman, Margitta Theodora; Landtblom, Anne Marie; Lauer, Klaus; Myhr, Kjell-Morten; Parpinel, Maria; Pekmezovic, Tatjana; Riise, Trond; Zhu, Bin; Wolfson, Christina. 2012. A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q). Acta Neurologica Scandinavica, Supplementum. 43-50.
  • Myhr, Kjell-Morten; Grytten, Nina Agnethe; Torkildsen, Øivind; Wergeland, Stig; Bø, Lars; Pugliatti, M; Aarseth, Jan Harald. 2012. A need for national registries and international collaborative research in multiple sclerosis. Acta Neurologica Scandinavica. 1-3.
  • Smedal, Tori; Myhr, Kjell-Morten; Aarseth, Jan Harald; Gjelsvik, Bente E Bassøe; Beiske, Antonie Giæver; Glad, Solveig B; Strand, Liv Inger. 2011. The influence of warm versus cold climate on the effect of physiotherapy in multiple sclerosis. Acta Neurologica Scandinavica. 45-52.
  • Riise, Trond; Kirkeleit, Jorunn; Aarseth, Jan Harald; Farbu, Elisabeth; Midgard, Rune; Mygland, Åse; Eikeland, Randi; Mørland, Tore; Telstad, Wenche; Førland, Per Tore; Myhr, Kjell-Morten. 2011. Risk of MS is not associated with exposure to crude oil, but increases with low level of education. Multiple Sclerosis. 780-787.
  • Risberg, Geir; Aarseth, Jan Harald; Nyland, Harald Inge; Lauer, K; Myhr, Kjell-Morten; Midgard, Rune. 2011. Prevalence and incidence of multiple sclerosis in Oppland County – a cross-sectional population-based study in a landlocked county of Eastern Norway. Acta Neurologica Scandinavica. 250-257.
  • Sørensen, Per Soelberg; Jensen, Poul Erik Hyldgaard; Haghikia, Aiden; Lundkvist, Maria; Vedeler, Christian A.; Sellebjerg, Finn; Koch-Henriksen, Nils; Fogdell-Hahn, Anna; Myhr, Kjell-Morten; Hillert, Jan; Gold, Ralf. 2011. Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab. Multiple Sclerosis. 1074-1078.
  • Glad, Solveig B; Nyland, Harald Inge; Aarseth, Jan Harald; Riise, Trond; Myhr, Kjell-Morten. 2011. How long can you keep working with benign multiple sclerosis? Journal of Neurology, Neurosurgery and Psychiatry. 78-82.
  • Sawcer, S; Hellenthal, G; Pirinen, M; Spencer, CCA; Patsopoulos, NA; Moutsianas, L; Dilthey, A; Su, Z; Freeman, C; Hunt, SE; Edkins, S; Gray, E; Booth, DR; Potter, SC; Goris, A; Band, G; Oturai, AB; Strange, A; Saarela, J; Bellenguez, C; Fontaine, B; Gillman, M; Hemmer, B; Gwilliam, R; Zipp, F; Jayakumar, A; Martin, R; Leslie, S; Hawkins, S; Giannoulatou, E; D'alfonso, S; Blackburn, H; Boneschi, FM; Liddle, J; Harbo, Hanne Flinstad; Perez, ML; Spurkland, Anne; Waller, MJ; Mycko, MP; Ricketts, M; Comabella, M; Hammond, N; Kockum, I; McCann, OT; Ban, M; Whittaker, P; Kemppinen, A; Weston, P; Hawkins, C; Widaa, S; Zajicek, J; Dronov, S; Robertson, N; Bumpstead, SJ; Barcellos, LF; Ravindrarajah, R; Abraham, R; Alfredsson, L; Ardlie, K; Aubin, C; Baker, A; Baker, K; Baranzini, SE; Bergamaschi, L; Bergamaschi, R; Bernstein, A; Berthele, A; Boggild, M; Bradfield, JP; Brassat, D; Broadley, SA; Buck, D; Butzkueven, H; Capra, R; Carroll, WM; Cavalla, P; Celius, Elisabeth Gulowsen; Cepok, S; Chiavacci, R; Clerget-Darpoux, F; Clysters, K; Comi, G; Cossburn, M; Cournu-Rebeix, I; Cox, MB; Cozen, W; Cree, BAC; Cross, AH; Cusi, D; Daly, MJ; Davis, E; de Bakker, PIW; Debouverie, M; D'hooghe, MB; Dixon, K; Dobosi, R; Dubois, B; Ellinghaus, D; Elovaara, I; Esposito, F. 2011. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 214-219.
  • Smedal, Tori; Beiske, Antonie Giæver; Glad, Solveig Bergliot; Myhr, Kjell-Morten; Aarseth, Jan Harald; Svensson, Elisabeth ; Gjelsvik, Bente E Bassøe; Strand, Liv Inger. 2011. Fatigue in multiple sclerosis: associations with health-related quality of life and physical performance. European Journal of Neurology. 114-120.
  • Mero, Inger-Lise; Ban, Maria; Lorentzen, Åslaug Rudjord; SMESTAD, CATHRINE; Celius, Elisabeth Gulowsen; Sæther, Hanne Skarpodde; Saeedi, Haleh; Viken, Marte K; Skinningsrud, Beate; Undlien, Dag Erik; Aarseth, Jan Harald; Myhr, Kjell-Morten; Granum, Stine; Spurkland, Anne; Sawcer, Stephen; Compston, Alastair; Lie, Benedicte Alexandra; Harbo, Hanne Flinstad. 2011. Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus. Genes and Immunity. 191-198.
  • Wergeland, Stig; Torkildsen, Øivind; Myhr, Kjell-Morten; Aksnes, Lage; Mørk, Sverre; Bø, Lars. 2011. Dietary vitamin D3 supplements reduce demyelination in the cuprizone model. PLOS ONE. 8 pages.
  • Søndergaard, Helle Bach; Sellebjerg, Finn; Hillert, Jan; Olsson, Tomas; Kockum, Ingrid; Lindén, Magdalena; Mero, Inger-Lise; Myhr, Kjell-Morten; Celius, Elisabeth Gulowsen; Harbo, Hanne Flinstad; Christensen, Jeppe Romme; Börnsen, Lars; Sørensen, Per Soelberg; Oturai, Annette Bang. 2011. Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655. European Journal of Human Genetics. 1100-1103.
  • Torkildsen, Øivind Fredvik; Stansberg, Christine; Angelskår, Solveig Mjelstad; Kooi, Evert-Jan; Geurts, Jeroen J.G.; van der Valk, Paul; Myhr, Kjell-Morten; Steen, Vidar Martin; Bø, Lars. 2010. Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathology. 720-729.
  • Smedal, Tori; Myhr, Kjell-Morten; Aarseth, Jan Harald; Gjelsvik, Bente E Bassøe; Beiske, Antonie Giæver; Glad, Solveig Bergliot; Strand, Liv Inger. 2010. The influence of warm versus cold climate on the effect of physiotherapy in multiple sclerosis. Acta Neurologica Scandinavica. 45-52.
  • Smedal, Tori; Johansen, Hilde Haukelid; Myhr, Kjell-Morten; Strand, Liv Inger. 2010. Psychometric properties of a Norwegian version of Multiple Sclerosis Impact Scale (MSIS-29). Acta Neurologica Scandinavica. 244-251.
  • Næss, Halvor; Glad, Solveig B; Storstein, Anette; Rinaldo, Christine H; Mørk, Sverre; Myhr, Kjell-Morten; Hirsch, Hans. 2010. Progressive multifocal leucoencephalopathy in an immunocompetent patient with favourable outcome. A case report. BMC Neurology. 4 pages.
  • Næss, Halvor; Sundal, Endre; Myhr, Kjell-Morten; Nyland, Harald Inge. 2010. Postinfectious and chronic fatigue syndromes: clinical experience from a tertiary-referral centre in Norway. In Vivo. 185-188.
  • Harbo, Hanne Flinstad; Riccio, Maria Elena; Lorentzen, Åslaug Rudjord; Utsi, Egil; Myhr, Kjell-Morten; Mellgren, Svein Ivar; Flåm, Siri T.; Thorsby, Erik; Sanchez-Mazas, Alicia; Lie, Benedicte A. 2010. Norwegian Sami differs significantly from other Norwegians according to their HLA profile. Tissue Antigens. 207-217.
  • Lode, Kirsten; Bru, Edvin; Klevan, Gry; Myhr, Kjell-Morten; Nyland, Harald Inge; Larsen, Jan Petter. 2010. Coping with multiple sclerosis: a 5-year follow-up study. Acta Neurologica Scandinavica. 336-342.
  • Glad, Solveig Bergliot; Aarseth, Jan Harald; Nyland, Harald Inge; Riise, Trond; Myhr, Kjell-Morten. 2010. Benign multiple sclerosis: a need for a consensus. Acta Neurologica Scandinavica. 44-50.
  • Lorentzen, Åslaug Rudjord; Melum, Espen; Ellinghaus, Eva; Smestad, Cathrine; Mero, Inger-Lise; Aarseth, Jan Harald; Myhr, Kjell-Morten; Celius, Elisabeth Gulowsen; Lie, Benedicte Alexandra; Karlsen, Tom Hemming; Franke, Andre; Harbo, Hanne Flinstad. 2010. Association to the Glypican-5 gene in multiple sclerosis. Journal of Neuroimmunology. 194-197.
  • Mero, Inger-Lise; Lorentzen, Åslaug Rudjord; SMESTAD, CATHRINE; Ban, Maria; Celius, Elisabeth Gulowsen; Aarseth, Jan; Myhr, Kjell-Morten; Link, Jenny; Olsson, Tomas; Hillert, Jan; Kockum, Ingrid; Masterman, T; Oturai, AB; Sondergaard, HB; Sellebjerg, F; Saarela, J; Kemppinen, A; Elovaara, I; Spurkland, Anne; Dudbridge, F; Lie, Benedicte Alexandra; Harbo, Hanne Flinstad. 2010. A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis. European Journal of Human Genetics. 502-504.
  • Kvalheim, Tarja Anniki Rajalahti; Kroksveen, Ann Cathrine; Arneberg, Reidar; Berven, Frode; Vedeler, Christian A.; Myhr, Kjell-Morten; Kvalheim, Olav Martin. 2010. A multivariate approach to reveal biomarker signatures for disease classification: application to mass spectral profiles of cerebrospinal fluid from patients with multiple sclerosis. Journal of Proteome Research. 3608-3620.
  • Myhr, Kjell-Morten. 2009. Vitamin D treatment in multiple sclerosis. Journal of the Neurological Sciences. 104-108.
  • Sorensen, PS; Mellgren, SI; Svenningsson, A; Elovaara, I; Fredriksen, JL; Beiske, Antonie Giæver; Myhr, Kjell-Morten; Søgaard, LV; Olsen, IC; Sandberg-Wollheim, M. 2009. NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial. Lancet Neurology. 519-529.
  • Sorensen, PS; Mellgren, Svein Ivar; Svenningsson, A; Elovaara, I; Frederiksen, JL; Beiske, AG; Myhr, K.-M.; Søgaard, LV; Olsen, IC; Wollheim, MS. 2009. NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial. Lancet Neurology. 519-529.
  • Glad, Solveig Bergljot; Nyland, Harald Inge; Aarseth, Jan Harald; Riise, Trond; Myhr, Kjell-Morten. 2009. Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway. Multiple Sclerosis. 942-950.
  • Torkildsen, Øivind Fredvik; Brunborg, Linn Anne; Thorsen, Frits Alan; Mørk, Sverre; Stangel, Martin; Myhr, Kjell-Morten; Bø, Lars. 2009. Effects of dietary intervention on MRI activity, de- and remyelination in the cuprizone model for demyelination. Experimental Neurology. 160-166.
  • Comi, G; Martinelli, V; Rodegher, M; Moiola, L; Bajenaru, O; Carra, A; Elkovaara, I; Fazekas, F; Hartung, HP; Hillert, J; King, J.; Komoly, S; Lubetzki, C; Montalban, X; Myhr, Kjell-Morten; Ravnborg, M; Rieckmann, P; Wynn, D; Young, C; Filippi, M. 2009. Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. The Lancet. 1503-1511.
  • Rajalahti, Tarja; Arneberg, Reidar; Kroksveen, Ann Cathrine; Berle, Magnus Foldal; Myhr, Kjell-Morten; Kvalheim, Olav Martin. 2009. Discriminating Variable Test and Selectivity Ratio Plot: Quantitative Tools for Interpretation and Variable (Biomarker) Selection in Complex Spectral or Chromatographic Profiles. Analytical Chemistry. 2581-2590.
  • Lode, Kirsten; Bru, Edvin; Klevan, Gry; Myhr, Kjell-Morten; Nyland, Harald Inge; Larsen, Jan Petter. 2009. Depressive symptoms and coping in newly diagnosed patients with multiple sclerosis. Multiple Sclerosis. 638-643.
  • Rajalahti, Tarja; Arneberg, Reidar; Berven, Frode; Myhr, Kjell-Morten; Ulvik, Rune Johan; Kvalheim, Olav Martin. 2009. Biomarker discovery in mass spectral profiles by means of selectivity ratio plot. Chemometrics and Intelligent Laboratory Systems. 35-48.
  • Aarskog, Nina Karin; Marøy, Tove; Myhr, Kjell-Morten; Vedeler, Christian A. 2009. Antibodies against interferon-beta in multiple sclerosis. Journal of Neuroimmunology. 148-150.
  • Torkildsen, Øivind Fredvik; Brunborg, Linn Anne; Milde, Anne Marita; Mørk, Sverre; Myhr, Kjell-Morten; Bø, Lars. 2009. A salmon based diet protects mice from behavioural changes in the cuprizone model for demyelination. Clinical Nutrition. 83-87.
  • Magitta, Ng'weina Francis; Wolff, Anette Susanne Bøe; Johansson, Stefan; Skinningsrud, Beate; Lie, Benedicte A; Myhr, Kjell-Morten; Undlien, Dag Erik; Joner, Geir; Njølstad, Pål Rasmus; Kvien, Tore K.; Førre, Øystein; Knappskog, Per Morten; Husebye, Eystein Sverre. 2009. A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes and Immunity. 120-124.
  • Yu, Xinhua; Koczan, Dirk; Sulonen, Anna-Maija; Akkad, Dennis A.; Kroner, Antje; Comabella, Manuel; Costa, Gianna; Corongiu, Daniela; Goertsches, Robert; Camina-Tato, Montserrat; Thiesen, Hans-Juergen; Nyland, Harald Inge; Mørk, Sverre; Montalban, Xavier; Rieckmann, Peter; Marrosu, Maria G.; Myhr, Kjell-Morten; Epplen, Joerg T.; Saarela, Janna; Ibrahim, Saleh M. 2008. mtDNA nt13708A Variant Increases the Risk of Multiple Sclerosis. PLOS ONE. 1-7.
  • Torkildsen, Øivind Fredvik; Knappskog, Per; Nyland, Harald Inge; Myhr, Kjell-Morten. 2008. Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis. Archives of Neurology. 809-811.
  • Torkildsen, Øivind Fredvik; Brunborg, Linn Anne Bjelland; Myhr, Kjell-Morten; Bø, Lars. 2008. The cuprizone model for demyelination. Acta Neurologica Scandinavica. 72-76.
  • Lorentzen, Åslaug R; Smestad, Cathrine; Lie, BA; Oturai, AB; Akesson, E; Saarela, Janna; Myhr, Kjell-Morten; Vartdal, Frode; Celius, Elisabeth G; Sorensen, PS; Hillert, Jan; Spurkland, Anne; Harbo, HF. 2008. The SH2D2A gene and susceptibility to multiple sclerosis. Journal of Neuroimmunology. 152-158.
  • Grytten, Nina Agnethe; Lie, Stein Atle; Aarseth, Jan Harald; Nyland, Harald Inge; Myhr, Kjell-Morten. 2008. Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway. Multiple Sclerosis. 1191-1198.
  • Figved, N; Benedict, R; Klevan, G; Myhr, Kjell-Morten; Nyland, Harald Inge; Landrø, Nils Inge; Larsen, Jan Petter; Aarsland, Dag. 2008. Relationship of cognitive impairment to psychiatric symptoms in multiple sclerosis. Multiple Sclerosis. 1084-1090.
  • Næss, Halvor; Beiske, Antonie Giæver; Myhr, Kjell-Morten. 2008. Quality of life among young patients with ischaemic stroke compared with patients with multiple sclerosis. Acta Neurologica Scandinavica. 181-185.
  • Dahl, J; Myhr, KM; Daltveit, Anne Kjersti Nesje; Gilhus, NE. 2008. Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. Journal of Neurology. 623-627.
  • Pugliatti, M.; Harbo, H.F.; Holmøy, T.; Kampman, Margitta Theodora; Myhr, K.-M.; Riise, T.; Wolfson, C. 2008. Environmental risk factors in multiple sclerosis. Acta Neurologica Scandinavica. 34-40.
  • Myhr, Kjell-Morten. 2008. Diagnosis and treatment of multiple sclerosis. Acta Neurologica Scandinavica. 12-21.
  • Beiske, AG; Svensson, Elisabeth Karin; Sandanger, I; Czujko, Berit; Pedersen, ED; Aarseth, J.H.; Myhr, KM. 2008. Depression and anxiety amongst multiple sclerosis patients. European Journal of Neurology. 239-245.
  • Magitta, Ng’weina Francis ; Bøe, AS; Johansson, S; Skinningsrud, Beate; Lie, Benedicte Alexandra; Myhr, KM; Undlien, Dag Erik; Joner, Geir; Njølstad, Pål R.; Kvien, Tore Kristian; Førre, Øystein Thorleiv; Knappskog, P.M.; Husebye, Eystein. 2008. A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes and Immunity.
  • Nortvedt, Monica; Riise, Trond; Frugård, Jannicke; Mohn, Jannike; Bakke, August; Skår, Anne Britt; Nyland, Harald Inge; Glad, Solveig B.; Myhr, Kjell-Morten. 2007. Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Multiple Sclerosis. 106-112.
  • Arneberg, Reidar; Rajalahti, Tarja; Flikka, Kristian; Berven, Frode; Kroksveen, Ann Cathrine; Berle, Magnus Foldal; Myhr, Kjell-Morten; Vedeler, Christian A.; Ulvik, Rune Johan; Kvalheim, Olav Martin. 2007. Pretreatment of mass spectral profiles: Application to proteomic data. Analytical Chemistry. 7014-7026.
  • Berven, Frode; Kroksveen, Ann Cathrine; Berle, Magnus Foldal; Rajalahti, Tarja; Flikka, Kristian; Arneberg, Reidar; Myhr, Kjell-Morten; Vedeler, Christian A.; Kvalheim, Olav Martin; Ulvik, Rune Johan. 2007. Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome. PROTEOMICS - Clinical Applications. 699-711.
  • Lode, Kirsten; Larsen, Jan Petter; Bru, Edvin; Klevan, Gry; Myhr, Kjell-Morten; Nyland, Harald Inge. 2007. Patient information and coping styles in multiple sclerosis. Multiple Sclerosis. 792-799.
  • Harbo, HF; Utsi, E; Lorentzen, AR; Kampman, Margitta Theodora; Celius, EG; Myhr, KM; Lie, BA; Mellgren, Svein Ivar; Thorsby, E. 2007. Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami. Tissue Antigens. 299-304.
  • Dahl, Julie; Myhr, Kjell-Morten; Daltveit, Anne Kjersti Nesje; Skjærven, Rolv; Gilhus, Nils Erik. 2007. Is smoking an extra hazard in pregnant MS women? Findings from a population-based registry in Norway. European Journal of Neurology. 1113-1117.
  • Torkildsen, Øivind Fredvik; Grytten, Nina Agnethe; Myhr, Kjell-Morten. 2007. Immunomodulatory treatment of multiple sclerosis in Norway. Acta Neurologica Scandinavica. 46-50.
  • Beiske, Antonie Giæver; Næss, Halvor; Aarseth, Jan Harald; Andersen, Oluf; Elovaara, Irina; Färkkilä, Markus; Hansen, Hans Jacob ; Mellgren, Svein Ivar; Sandberg-Wollheim, Magnhild; Sørensen, Per Soelberg; Myhr, Kjell-Morten. 2007. Health-related quality of life in secondary progressive multiple sclerosis. Multiple Sclerosis. 386-392.
  • Beiske, AG; Naess, H; Aarseth, JH; Andersen, O; Elovaara, I; Farkkila, M; Hansen, HJ; Mellgren, Svein Ivar; Sandberg-Wollheim, M; Sorensen, PS; Myhr, KM; The Nordic SPMS, study group. 2007. Health-related quality of life in secondary progressive multiple sclerosis. Multiple Sclerosis. 386-392.
  • Wolff, Anette Susanne Bøe; Myhr, Kjell-Morten; Vedeler, Christian A.; Husebye, Eystein S.Junior. 2007. Fc gamma receptor polymorphisms are not associated with autoimmune Addison's disease. Scandinavian Journal of Immunology. 555-558.
  • Hensiek, Anke E.; Seaman, Shaun Robert ; Barcellos, Lisa F.; Oturai, Annette; Eraksoi, M.; Cocco, Eleonora; Vecsei, László; Stewart, Graeme; Dubois, Bénédicte; Bellman-Strobl, J; Leone, Maurizio ; Andersen, Oluf; Bencsik, Krisztina; Booth, David; Celius, Elisabeth G; Harbo, Hanne F; Hauser, Stephen L.; Heard, Rob; Hillert, Jan; Myhr, Kjell-Morten; Marrosu, Maria Giovanna ; Oksenberg, Jorge R.; Rajda, Cecilia; Sawcer, Stephen J.; Sørensen, Per Soelberg; Zipp, Fruke; Compston, D. Alastair S. 2007. Familial effects on the clinical course of multiple sclerosis. Neurology. 376-383.
  • Figved, Nanna; Myhr, Kjell-Morten; Larsen, Jan Petter; Aarsland, Dag. 2007. Caregiver burden in multiple sclerosis: the impact of neuropsychiatric symptoms. Journal of Neurology, Neurosurgery and Psychiatry. 1097-1102.
  • Datta, Pameli; Harbo, Hanne F; Ryder, Lars P.; Åkesson, Elisabeth; Benedikz, John; Celius, Elisabeth G; Andersen, Oluf; Myhr, Kjell-Morten; Sandberg-Wollheim, Magnhild; Hillert, Jan; Svejgaard, Arne; Sørensen, Per Soelberg; Spurkland, Anne; Oturai, Annette. 2007. A follow-up study of Nordic multiple sclerosis candidate gene regions. Multiple Sclerosis. 584-589.
  • Myhr, Kjell-Morten; Grytten, Nina; Aarseth, Jan Harald; Nyland, Harald Inge. 2006. The Norwegian Multiple Sclerosis National Competence Centre and National Multiple Sclerosis Registry - a resource for clinical practice and research. Acta Neurologica Scandinavica. 37-40.
  • Dahl, Julie; Myhr, Kjell-morten; Daltveit, Anne Kjersti Nesje; Gilhus, Nils erik. 2006. Planned vaginal births in women with multiple sclerosis: delivery and birth outcome. Acta Neurologica Scandinavica. 51-54.
  • Dahl, Julie; Myhr, Kjell-Morten; Daltveit, Anne Kjersti; Gilhus, Nils Erik. 2006. Planned vaginal births in women with multiple sclerosis: delivery and birth outcome. Acta Neurologica Scandinavica. 51-54.
  • Myhr, Kjell-Morten. 2006. Multippel sklerose. Norsk tidsskrift for logopedi. 5-9.
  • Gavasso, Sonia; Myhr, Kjell-Morten; Vedeler, Christian A. 2006. Multiplexed phosphoprotein analysis in immune cells. Acta Neurologica Scandinavica. 58-60.
  • Næss, Halvor; Waje-Andreassen, Ulrike; Thomassen, Lars; Nyland, Harald Inge; Myhr, Kjell-Morten. 2006. Health-related quality of life among young adults with ischemic stroke on long-term follow-up. Stroke. 1232-2336.
  • Torkildsen, Øivind Fredvik; Vedeler, Christian A.; Nyland, Harald Inge; Myhr, Kjell-Morten. 2006. Fc gamma R and multiple sclerosis: an overview. Acta Neurologica Scandinavica. 61-63.
  • Glad, Solveig; Nyland, Harald Inge; Myhr, Kjell-Morten. 2006. Benign multiple sclerosis. Acta Neurologica Scandinavica. 55-57.
  • Grytten, Nina Agnethe; Glad, Solveig B.; Aarseth, Jan Harald; Nyland, Harald Inge; Midgard, Rune; Myhr, Kjell-Morten. 2006. A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway. Neurology. 182-186.
  • Dahl, Julie; Myhr, Kjell-Morten; Daltveit, Anne Kjersti; Hoff, Jana Midelfart; Gilhus, Nils Erik. 2005. Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology. 1961-1963.
  • Figved, Nanna; Klevan, Gry; Myhr, Kjell-Morten; Glad, Solveig; Nyland, Harald Inge; Larsen, Jan Petter; Harboe, Erna; Omdal, Roald; Aarsland, Dag. 2005. Neuropsychiatric symptoms in patients with multiple sclerosis. Acta Psychiatrica Scandinavica. 463-468.
  • Næss, Halvor; Nyland, Harald Inge; Thomassen, Lars; Aarseth, Jan Harald; Myhr, Kjell-Morten. 2005. Mild depression in young adults with cerebral infarction at long-term follow-up: A population-based study. European Journal of Neurology. 194-198.
  • Lorentzen, Åslaug Rudjord; Celius, Elisabeth Gulowsen; Ekstrøm, Per Olaf; Wiencke, Kristine; Lie, Benedicte Alexandra; Myhr, KM; Ling, V; Thorsby, Erik; Vartdal, Frode; Spurkland, Anne; Harbo, Hanne Flinstad. 2005. Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients. Journal of Neuroimmunology. 5 pages.
  • Torkildsen, Øivind Fredvik; Vedeler, Christian A.; Ulvestad, Elling; Aarseth, Jan Harald; Nyland, Harald Inge; Myhr, Kjell-Morten. 2005. High dose methylprednisolone induces FcgammaR1 on granulocytes in MS-patients. Journal of Neuroimmunology. 138-142.
  • Gavasso, Sonia; Nygård, Ottar; Pedersen, Eva Kristine Ringdal; Aarseth, Jan Harald; Bleie, Øyvind; Myhr, Kjell-Morten; Vedeler, Christian A. 2005. Fc gamma receptor IIIA polymorphism as a risk-factor for coronary artery disease. Atherosclerosis. 277-282.
  • Næss, Halvor; Nyland, Harald Inge; Thomassen, Lars; Aarseth, Jan Harald; Myhr, Kjell-Morten. 2005. Fatigue at long-term follow-up in young adults with cerebral infarction. Cerebrovascular Diseases. 245-250.
  • Torkildsen, O; Torkildsen, Øivind Fredvik; Utsi, Egil; Harbo, Hanne F; Mellgren, Svein Ivar; Vedeler, Christian A.; Myhr, Kjell-Morten. 2005. Ethnic variations of IL-10 polymorphisms in a Sami and Norwegian population. Scandinavian Journal of Immunology. 71-74.
  • Torkildsen, Øivind Fredvik; Utsi, Egil; Mellgren, Svein Ivar; Harbo, Hanne F; Vedeler, Christian A.; Myhr, Kjell-Morten. 2005. Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations. Immunology. 416-421.
  • Torkildsen, Øyvind; Utsi, Egil; Mellgren, Svein Ivar; Harbo, Hanne F.; Vedeler, Christian A.; Myhr, Kjell-Morten. 2005. Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations. Immunology. 416-421.
  • Torkildsen, Øyvind; Utsi, Egil; Harbo, Hanne F.; Mellgren, Svein Ivar; Vedeler, Christian A.; Myhr, Kjell-Morten. 2005. Ethnic Variations of IL-10 Polymorphisms in a Sami and Norwegian Population. Scandinavian Journal of Immunology. 71-74.
  • Næss, Halvor; Waje-Andreassen, Ulrike; Thomassen, Lars; Nyland, Harald Inge; Myhr, Kjell-Morten. 2005. Do all young ischemic stroke patients need long-term secondary preventive medication? Neurology. 609-611.
  • Andersen, O; Elovaara, I; Farkkila, M; Hansen, HJ; Mellgren, Svein Ivar; Myhr, KM; Sandberg-Wolheim, M; Sorensen, PS. 2004. Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry. 706-710.
  • Naess, H; Nyland, Harald Inge; Thomassen, L; Aarseth, J; Myhr, KM. 2004. Long-term outcome of cerebral infarction in young adults. Acta Neurologica Scandinavica. 107-112.
  • Harbo, HF; Lie, BA; Sawcer, S; Celius, EG; Dai, KZ; Oturai, A; Hillert, J; Lorentzen, AR; Laaksonen, M; Myhr, KM; Ryder, LP; Fredrikson, S; Nyland, H; Sorensen, PS; Sandberg-Wolheim, M; Andersen, O; Svejgaard, A; Edland, A; Mellgren, Svein Ivar; Compston, A; Vartdal, F; Spurkland, A. 2004. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens. 237-247.
  • Naess, H; Nyland, Harald Inge; Thomassen, L; Aarseth, J; Myhr, KM. 2004. Etiology of and risk factors for cerebral infarction in young adults in western Norway: a population-based case-control study. European Journal of Neurology. 25-30.
  • Oturai, AB; Ryder, LP; Fredrikson, S; Myhr, KM; Celius, EG; Harbo, HF; Andersen, O; Akesson, E; Hillert, J; Madsen, HO; Nyland, Harald Inge; Spurkland, A; Datta, P; Svejgaard, A; Sorensenl, PS. 2004. Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs. Multiple Sclerosis. 5-8.
Academic lecture
  • Røsjø, Egil Rørvik; Myhr, Kjell-Morten; Kampman, Margitta Theodora; Løken-Amsrud, Kristin Ingeleiv; Steffensen, Linn Hofsøy; Bakke, Søren Jacob; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Lilleås, Finn; Midgard, Rune; Pedersen, Tom; Benth, Jūratė Šaltytė; Lindstrøm, Jonas Christoffer; Mellgren, Svein Ivar; Jørgensen, Lone; Torkildsen, Øivind; Wergeland, Stig; Michelsen, Annika; Aukrust, Pål; Ueland, Thor; Holmøy, Trygve. 2015. Vitamin D og interferon-behandling ved multippel sklerose.
  • Cortese, Marianna; Riise, Trond; Bjørnevik, Kjetil Lauvland; Farbu, Elisabeth; Grytten, Nina ; HogenEsch, Ineke; Midgard, Rune; Simonsen, Cecilia Smith; Telstad, Wenche; Myhr, Kjell-Morten. 2015. Evidence of preclinical disease activity­ a prospective study on cognitive and physical performance prior to first symptom of multiple sclerosis.
  • Bjørnevik, Kjetil Lauvland; Riise, Trond; Kirkeleit, Jorunn; Cortese, Marianna; Holmøy, Trygve; Kampman, Margitta Theodora; Magalhaes, Sandra; Myhr, Kjell-Morten; Wolfson, Christina; Pugliatti, Maura. 2014. Level of education and multiple sclerosis risk after adjustment for known risk factors: the EnvIMS study.
  • Kvalheim, Olav Martin; Rajalahti, Tarja; Arneberg, Reidar; Berven, Frode; Kroksveen, Ann Cathrine; Berle, Magnus; Flikka, Kristian; Myhr, Kjell-Morten; Vedeler, Christian A.; Ulvik, Rune Johan. 2007. Target projection and proper data pre-treatment for the analysis of proteomic profiles.
  • Rajalahti, Tarja; Arneberg, Reidar; Flikka, Kristian; Berven, Frode; Kroksveen, Ann Cathrine; Berle, Magnus; Myhr, Kjell-Morten; Vedeler, Christian A.; Ulvik, Rune Johan; Kvalheim, Olav Martin. 2007. Preteatment of Mass Spectral Profiles: Application to proteomic data.
  • Kvalheim, Olav Martin; Rajalahti, Tarja; Arneberg, Reidar; Berven, Frode; Kroksveen, Ann Cathrine; Berle, Magnus; Flikka, Kristian; Myhr, Kjell-Morten; Vedeler, Christian A.; Ulvik, Rune Johan. 2007. Analysis of Proteomic Profiles.
  • Svendsen, Bjørn; Myhr, Kjell-Morten; Nyland, Harald; Aarseth, Jan Harald. 2006. Costs and quality of life in patients with multiple sclerosis in Norway compared to 9 other European countries.
  • Nortvedt, Monica Wammen; Riise, Trond; Myhr, Kjell-Morten; Nyland, Harald I. 2000. Reduced quality of life among MS patients with sexual disturbance and bladder dysfunction.
  • Riise, Trond; Nortvedt, Monica Wammen; Myhr, Kjell-Morten; Nyland, Harald I. 2000. Quality of life as a predictor for change in disability in multiple sclerosis.
  • Nortvedt, Monica Wammen; Riise, Trond; Myhr, Kjell-Morten; Nyland, Harald I; Hanestad, Berit R. 2000. Livskvalitet hos multippel sklerose pasienter - en utfordring for sykepleien.
  • Nortvedt, Monica Wammen; Riise, Trond; Myhr, Kjell-Morten; Nyland, Harald I; Hanestad, Berit R. 2000. Livskvalitet hos multippel sklerose pasienter.
  • Nortvedt, Monica Wammen; Riise, Trond; Myhr, Kjell-Morten; Nyland, Harald. 1999. The quality of life of multiple sclerosis patients in a treatment trial with recombinant interferon-alfa-2a.
  • Riise, Trond; Nortvedt, Monica Wammen; Myhr, Kjell-Morten; Nyland, Harald. 1999. Lack of agreement between objective disease measures and the Quality of Life in a treatment trial in multiple sclerosis.
  • Nortvedt, Monica Wammen; Riise, Trond; Myhr, Kjell-Morten; Hanestad, Berit Rokne; Nyland, Harald. 1999. Expanded Disability Status Scale scores and the Quality of Life of Multiple Sclerosis patients. An epidemiological study.
Abstract
  • Torkildsen, Øivind; Myhr, Kjell-Morten; Beiske, Antonie Giæver; Bjerve, Kristian S; Hovdal, Harald Olav; Midgard, Rune; Riise, Trond; Wergeland, Stig; Bjørnevik, Kjetil Lauvland. 2017. alpha-Linolenic acid (ALA) serum levels are associated with reduced MRI activity in a prospective cohort of MS patients. Multiple Sclerosis. 712-712.
  • Nina, Grytten; Benjaminsen, Espen; Celius, Elisabeth Gulowsen; Kampman, Margitta Theodora; Midgard, Rune; Myhr, Kjell-Morten; Riise, Trond; Torkildsen, Øivind; Aarseth, Jan Harald. 2017. Cancer risk in multiple sclerosis. Multiple Sclerosis. 486-487.
  • Kuhle, Jens; Dobson, R; Bestwick, JP; Topping, J; Dalla Costa, G; Khademi, M; Sombekke, M; Killestein, J; Evdoshenko, E; Lazareva, N; Runia, T; Zbornikova, P; Horakova, D; D'Alfonso, S; Thouvenot, E; Moll, N; Hegen, H; Rauch, S; Khalil, M; Fuchs, S; Lindberg, RLP; Derfuss, T; Llufriu, S; Franciotta, D; Roesler, R; Lauda, F; Rajda, C; Drulovic, J; Menge, T; Kieseier, BC; Avsar, T; Marignier, R; Malmestrom, C; Myhr, Kjell-Morten; Wergeland, Stig; Annibali, V; Romano, S; Carra, A; Laroni, A; Frederiksen, JL; Larsson, HB; Uccelli, A; Martinez, AD; Salvetti, M; Torkildsen, O; Lycke, J; Confavreux, C; Rejdak, K; Bosca, I; Brassat, D; Scarpini, E; Fenoglio, C; Galimberti, D; Siva, A; Hartung, HP; Dujmovic, I; Vecsei, L; Tumani, H; Bergamaschi, R; Colombo, E; Villoslada, P; Saiz, A; Enzinger, C; Kappos, L; Deisenhammer, F; Alvarez-Cermeno, JC; Villar, L; Pelletier, J; Lehmann, S; Castelnovo, G; Barizzone, N; Leone, M; Havrdova, E; Trojano, M; Iaffaldano, P; Direnzo, V; Comabella, M; Tintore, M; Montalban, X; Hintzen, R; Lapin, S; Teunissen, C; Piehl, F; Olsson, T; Furlan, R; Martinelli, V; Comi, G; Ramagopalan, S; Giovannoni, G. 2013. Multivariate clinically isolated syndrome (CIS) risk factor study: towards individual prognosis and treatment indication in CIS. Multiple Sclerosis. 33-34.
  • Kvistad, SS; Myhr, Kjell-Morten; Holmøy, Trygve; Bakke, S.; Beiske, Antonie Giæver; Bjerve, Kristian S; Bjornara, BT; Hovdal, Harald Olav; Loken, KI; Lilleås, F; Midgard, Rune; Njølstad, Gro; Pedersen, T; Benth, JS; Wergeland, Stig; Torkildsen, Øivind. 2013. Antibodies to Epstein-Barr virus and disease activity in multiple sclerosis. Multiple Sclerosis. 400-400.
  • Oen, K J; Myhr, Kjell-Morten; Skar, A B R; Brandal, K M; Smedal, Tori. 2012. WalkAide - A multidisciplinary model for adjustment and evaluation. Multiple Sclerosis. S30-S30.
  • Gavasso, Sonia; Marøy, Tove Helene; Mosleth, Ellen Færgestad; Jørgensen, Katarina Mariann; Nakkestad, Hanne Linda; Gjertsen, Bjørn Tore; Myhr, Kjell-Morten; Vedeler, Christian A. 2012. Single cell pStat1 activation, a promising biomarker to evaluate neutralizing antibody effects in interferon-beta treated multiple sclerosis patients. Journal of Neuroimmunology. 18-19.
  • Lunde, Hanne Marie; Aae, Tommy F; Indrevåg, William; Aarseth, Jan Harald; Myhr, Kjell-Morten; Bjorvatn, Bjarne; Bø, Lars. 2012. Poor sleep in patients with multiple sclerosis. European Journal of Neurology. 706-706.
  • Wesnes, Kristin; Riise, Trond; Pugliatti, M; Myhr, Kjell-Morten. 2012. Overweight as a risk factor for multiple sclerosis. European Journal of Neurology. 353-353.
  • Nordvåg, Bjørn-Yngvar; Bernklev, Tomm; Slevolden, Ellen Margrethe; Myhr, Kjell-Morten; Stensland, Eva. 2012. Norwegian quality registry for biological drugs: the NOKBIL project. Scandinavian Journal of Rheumatology. 50-50.
  • Bjørnevik, Kjetil Lauvland; Riise, Trond; Wesnes, Kristin; Granieri, Enrico; Casetta, Ilaria; Drulovic, Jelena; Myhr, Kjell-Morten; Lauer, Klaus; Kampman, Margitta Theodora; Magalhaes, Sandra; Pekmezovic, Tatjana; Holmøy, Trygve; Landtblom, Anne-marie; Wolfson, Christina; Pugliatti, Maura. 2012. An age at exposure effect between sun exposure and the risk of MS in Norway and Italy. Multiple Sclerosis. s15-s15.
  • Myhr, Kjell-Morten. 2011. VITAMIN D, LIFESTYLE FACTORS AND RISK OF MULTIPLE SCLEROSIS. European Journal of Neurology. 16-16.
  • Kirkeleit, Jorunn; Riise, Trond; Aarseth, Jan Harald; Farbu, Elisabeth; Midgard, Rune; Mygland, Åse; Mørland, Tore; Eikeland, Randi; Telstad, Wenche; Førland, Per Tore; Myhr, Kjell-Morten. 2011. The Risk of Multiple Sclerosis Among Petroleum Workers Exposed to Crude Oil and Other Hydrocarbons. Epidemiology. S60-S60.
  • Lorentzen, Åslaug Rudjord; Melum, Espen; Buchert, Eva; SMESTAD, CATHRINE; Mero, Inger-Lise; Aarseth, Jan Harald; Myhr, Kjell-Morten; Celius, Elisabeth Gulowsen; Lie, Benedicte Alexandra; Karlsen, Tom Hemming; Franke, Andre; Harbo, Hanne Flinstad. 2010. Trend of association to the Glypican 5 gene region to multiple sclerosis. European Journal of Neurology. 221-221.
  • Glad, Solveig B; Aarseth, Jan Harald; Nyland, Harald Inge; Riise, Trond; Myhr, Kjell-Morten. 2010. The definition of benign multiple sclerosis: a methodical approach. European Journal of Neurology. 494-494.
  • Stansberg, Christine; Angelska, S; Kooi, Evert-Jan; Geurts, J; van der Valk, Paul; Myhr, Kjell-Morten; Steen, V; Bo, L; Torkildsen, Øivind Fredvik. 2009. Massive up-regulation of immunoglobulin-related genes in the meninges of multiple sclerosis patients without evidence for Epstein-Barr virus infection. Multiple Sclerosis. S5-S5.
  • Pugliatti, M.; Casetta, I; Cossu, P; De Gennaro, R; Drulovic, J; Granieri, E; Holmøy, T.; Kampman, Margitta Theodora; Landtblom, AM; Lauer, K; Myhr, Kjell-Morten; Pekmezovic, T; Riise, T.; Wolfson, C. 2009. International case control study on risk factors for multiple sclerosis (MS): pilot testing the questionnaire. Multiple Sclerosis. 1403-1403.
  • Wergeland, Stig; Torkildsen, Øivind Fredvik; Myhr, Kjell-Morten; Mørk, Sverre; Bø, Lars. 2009. Histopathological characterisation of the cuprizone model for demyelination. Multiple Sclerosis. S177-S177.
  • Smedal, Tori; Beiske, Antonie Giæver; Aarseth, Jan Harald; Glad, Solveig Bergliot; Strand, Liv Inger; Myhr, Kjell-Morten. 2009. Fatigue in multiple sclerosis is associated with self-perceived health, but less with physical performance. Multiple Sclerosis. S225-S225.
  • Gavasso, Sonia; Skavland, Jørn; Gjertsen, Bjørn Tore; Myhr, Kjell-Morten; Vedeler, Christian A. 2008. Interferon-beta signal transduction, multiple sclerosis and auto-antibodies. Journal of Neuroimmunology. 134-135.
  • Smedal, Tori; Myhr, Kjell-Morten; Gjelsvik, Bente; Beiske, Antonie Giæver; Glad, Solveig Bergljot; Skår, Anne Britt; Huser, Kari-Anne; Aarseth, Jan Harald; Strand, Liv Inger. 2008. Gait and balance improved in patients with multiple sclerosis after inpatient physiotherapy. Multiple Sclerosis. S152-S152.
  • Torkildsen, Øivind Fredvik; Brunborg, Linn Anne Bjelland; Milde, Anne Marita; Myhr, Kjell-Morten; Bø, Lars. 2008. Fish diet prevents impaired mobility in the murine cuprizone model for multiple sclerosis. Multiple Sclerosis. S90-S91.
  • Rajalahti, Tarja; Arneberg, Reidar; Berven, Frode; Kroksveen, Ann Cathrine; Berle, Magnus Foldal; Myhr, Kjell-Morten; Vedeler, Christian A.; Ulvik, Rune Johan; Kvalheim, Olav Martin. 2008. Early diagnosis and biomarker discovery from mass spectral profiles: application to multiple sclerosis. Multiple Sclerosis. S285-S285.
  • Rajalahti, Tarja; Arneberg, Reidar; Berven, Frode; Kroksveen, Ann Cathrine; Berle, Magnus Foldal; Myhr, Kjell-Morten; Vedeler, Christian A.; Ulvik, Rune Johan; Kvalheim, Olav Martin. 2008. Biomarker discovery from mass spectral profiles: A combined proteomics and multivariate analysis. European Journal of Pharmaceutical Sciences. S27-S27.
  • Pugliatti, Maura; Casetta, Ilaria; Cossu, Paola; De Gennaro, Riccardo; Drulovic, Jelena; Granieri, Enrico; Holmøy, Trygve; Kampman, Margitta Theodora; Landtblom, Anne-Marie; Lauer, Klaus; Myhr, Kjell-Morten; Pekmezovic, Tatjana; Riise, Trond; Wolfson, Christina. 2008. An international case-control study of risk factors for multiple sclerosis. Multiple Sclerosis. S197-S197.
  • Pugliatti, Maura; Casetta, Ilaria; Cossu, Paola; De Gennaro, Riccardo; Drulovic, Jelena; Granieri, Enrico; Holmøy, Trygve; Kampman, Margitta Theodora; Landtblom, Anne-Marie; Lauer, Klaus; Myhr, Kjell-Morten; Pekmezovic, Tatjana; Riise, Trond; Wolfson, Christina. 2008. Acceptability and cross-cultural feasibility of it self-administered questionnaire on past exposure to putative environmental risk factors for multiple sclerosis. Multiple Sclerosis. S196-S196.
  • Dahl, Julie; Myhr, Kjell-Morten; Daltveit, Anne Kjersti; Skjaerven, Rolv; Gilhus, Nils Erik. 2007. Smoking habits in pregnant MS women. European Journal of Neurology. 278-278.
  • Dahl, Julie; Myhr, Kjell-Morten; Daltveit, Anne Kjersti; Gilhus, Nils Erik. 2007. Perinatal factors and later development of multiple sclerosis. Multiple Sclerosis. S91-S92.
  • Beiske, Antonie Giæver; Smedal, Tori; Glad, Solveig B.; Gjelsvik, Olav; Gjelsvik, Bente; Skår, Anne Britt; Huser, Karianne A.; Aarseth, Jan Harald; Myhr, Kjell-Morten. 2007. Individualised physiotherapy improved fatigue score in patients with multiple sclerosis. Multiple Sclerosis. S127-S127.
  • Grytten, Nina Agnethe; Torkildsen, Øivind Fredvik; Aarseth, Jan Harald; Nyland, Harald Inge; Aarsland, Dag; Myhr, Kjell-Morten. 2007. Increasing prevalence of multiple sclerosis in the elderly in western Norway. Multiple Sclerosis. S96-S96.
  • Lorentzen, AR; SMESTAD, CATHRINE; Ekstrøm, Per Olaf; Oturai, Annette Bang; Åkesson, Eva; Saarela, Janna; Myhr, Kjell-Morten; Lie, Benedicte Alexandra; Celius, Elisabeth Gulowsen; Sorensen, PS; Hillert, Jan; Spurkland, Anne; Harbo, Hanne Flinstad. 2006. The role of SH2D2A gene polymorphisms in multiple sclerosis. Multiple Sclerosis. S72-S72.
  • Lorentzen, Åslaug Rudjord; Smestad, C.; Ekström, Peter; Oturai, AB; Åkesson, Elisabeth; Saarela, J.; Myhr, Kjell-Morten. 2006. The role of SH2D2A gene polymorphisms in development of multiple sclerosis. Tissue Antigens. 528-529.
  • Dahl, J; Myhr, KM; Daltveit, Anne Kjersti; Gilhus, Nils Erik. 2006. Pregnancy, delivery and birth outcome in mothers prior to debut of multiple sclerosis. European Journal of Neurology. 28-29.
  • Harbo, Hanne Flinstad; Utsi, E; Lorentzen, Åslaug Rudjord; T Kampman, M; Celius, EG; Myhr, KM; Lie, BA. 2006. Low prevalence of multiple sclerosis in a Sami population is related to low frequency of the disease-associated HLA DR15-DQ6 haplotype. Tissue Antigens. 523-523.
  • Harbo, HF; Utsi, Egil; Kampman, Margitta Theodora; Celius, EG; Myhr, KM; Lie, BA; Mellgren, Svein Ivar; Thorsby, E. 2006. Low prevalence of multiple sclerosis and the HLA CR15-DQ6 halotype in Sami. Multiple Sclerosis. 71-71.
  • Beiske, Antonie Giæver; Næss, Halvor; Aarseth, Jan Harald; Andersen, O; Elovaara, I; Farkkila, M; Hansen, HJ; Mellgren, Svein Ivar; Sandberg-Wollheim, M; Sørensen, PS; Myhr, Kjell-Morten. 2006. Health-related quality of life in secondary progressive multiple sclerosis. European Journal of Neurology. 27-27.
  • Lorentzen, Åslaug Rudjord; Celius, EG; Ekstrom, P; Wiencke, Kristine; Lie, Benedicte Alexandra; Myhr, KM; Ling, V; Thorsby, Erik; Vartdal, Frode; Spurkland, Anne; Harbo, Hanne Flinstad. 2005. The CD28/CTLA4/ICOS gene region does not show assosiation in Norwegian multiple sclerosis patients. Genes and Immunity. 1 pages.
Academic literature review
  • Varhaug, Kristin Nielsen; Torkildsen, Øivind; Myhr, Kjell-Morten; Vedeler, Christian A. 2019. Neurofilament light chain as a biomarker in multiple sclerosis. 1-6.
  • Myhr, Kjell-Morten; Torkildsen, Øivind; Lossius, Peter Andreas Vold; Bø, Lars; Holmøy, Trygve. 2019. B cell depletion in the treatment of multiple sclerosis. 261-271.
  • Alstadhaug, Karl Bjørnar; Myhr, Kjell-Morten; Rinaldo, Christine Hanssen. 2017. Progressive multifocal leukoencephalopathy. 10 pages.
  • Grytten, Nina ; Torkildsen, Øivind; Myhr, Kjell-Morten. 2015. Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades. 29-36.
  • Myhr, Kjell-Morten; Grytten, Nina ; Torkildsen, Øivind; Wergeland, Stig; Bø, Lars; Aarseth, Jan Harald. 2015. The Norwegian Multiple Sclerosis Registry and Biobank. 24-28.
  • Flachenecker, Peter; Buckow, Karoline; Pugliatti, Maura; Kes, Vanja Basic; Battaglia, Mario A.; Boyko, Alexey; Confavreux, Christian; Ellenberger, David; Eskic, Danica; Ford, David; Friede, Tim; Fuge, Jan; Glaser, Anna; Hillert, Jan; Holloway, Edward; Ioannidou, Eva; Kappos, Ludwig; Kasilingam, Elisabeth; Koch-Henriksen, Nils; Kuhle, Jens; Lepore, Vito; Middleton, Rod; Myhr, Kjell-Morten; Orologas, Anastasios; Otero, Susana; Pitschnau-Michel, Dorothea; Rienhoff, Otto; Sastre-Garriga, Jaume; Schyns-Liharska, Tsveta; Sutovic, Dragana; Thalheim, Christoph; Trojano, Maria; Vlasov, Yan V.; Yaldizli, Özgür. 2014. Multiple sclerosis registries in Europe - Results of a systematic survey. 1523-1532.
  • Gnanapavan, Sharmilee; Hegen, Harald; Khalil, Marwan; Hemmer, Bjørn; Franciotta, Diego; Hughes, Steve; Hintzen, Rogier; Jeromin, Andreas; Havrdova, Eva; Tumani, Hayrettin; Bertolotto, Antonio; Comabella, Manuel; Frederiksen, Jette L.; Álvarez-Cermeño, José C; Villar, Luisa Maria; Galimberti, Daniela; Myhr, Kjell-Morten; Dujmovic, Irena; Fazekas, Franz; Ionete, Carolina; Menge, Til; Kuhle, Jens; Keir, Geoffery; Deisenhammer, Florian; Teunissen, Charlotte; Giovannoni, Gavin. 2014. Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders. 1210-1216.
  • Stokke, Silje Agnethe; Wergeland, Stig; Torkildsen, Øivind; Myhr, Kjell-Morten; Vedeler, Christian A. 2013. Neuromyelitis optica. 2057-2061.
  • Lunde, Hanne Marie; Bjorvatn, Bjørn; Myhr, Kjell-Morten; Bø, Lars. 2013. Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review. 24-30.
  • Wergeland, Stig; Torkildsen, Øivind; Bø, Lars; Myhr, Kjell-Morten. 2012. Polyunsaturated fatty acids in multiple sclerosis therapy. 70-75.
  • Myhr, K M; Mellgren, Svein Ivar. 2009. Corticosteroids in the treatment of multiple sclerosis. 73-80.
  • Midgard, R; Beiske, AG; Celius, EG; Jensen, D; Hovdal, H; Mellgren, Svein Ivar; Myhr, KM. 2003. New diagnostic criteria in multiple sclerosis. 1345-1348.

More information in national current research information system (CRIStin)